Results 91 to 100 of about 5,788 (178)

Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual

Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley   +1 more source

A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivity.

PLoS Pathogens, 2014
Widely used chemical genetic screens have greatly facilitated the identification of many antiviral agents. However, the regions of interaction and inhibitory mechanisms of many therapeutic candidates have yet to be elucidated.
Hangfei Qi, C Anders Olson, Nicholas C Wu, Ruian Ke, Claude Loverdo, Virginia Chu, Shawna Truong, Roland Remenyi, Zugen Chen, Yushen Du, Sheng-Yao Su, Laith Q Al-Mawsawi, Ting-Ting Wu, Shu-Hua Chen, Chung-Yen Lin, Weidong Zhong, James O Lloyd-Smith, Ren Sun   +17 more
doaj   +1 more source

New drugs: Daclatasvir [PDF]

Australian Prescriber, 2015
openaire   +2 more sources

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection

, 2016
International audienceBACKGROUND & AIMS:We evaluated the combination of daclatasvir (pan-genotypic NS5A inhibitor) and simeprevir (NS3/4A protease inhibitor), with or without ribavirin, in hepatitis C virus genotype 1-infected patients.METHODS:This phase
Buti, Maria, Ouwerkerk-Mahadevan, Sivi, Cheung, Kin, Bronowicki, Jean-Pierre, Loustaud-Ratti, Veronique, Beumont-Mauviel, Maria, Makara, Mihaly, Mcphee, Fiona, Hughes, Eric A., Pruitt, Ronald, Al-Assi, M. Tarek, Noviello, Stephanie, Gea, Francisco, Thabut, Dominique, Olveira, Antonio, Gadano, Adrian, Petersen, Joerg, Bifano, Marc, Bourliere, Marc, Picchio, Gaston, Boparai, Navdeep, Pol, Stanislas, Hezode, Christophe, Banyai, Tivadar, Zeuzem, Stefan   +24 more
core   +1 more source

The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets

, 2019
The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis ...
Sharifi, A. H., Shayesteh, A. A., Moini, M., Latifnia, M., Somi, M. H., Fattahi, M. R., Roozbeh, F., Maleki, I., Amiriani, T., Sofian, M., Malekzadeh, R., Afshar, B., Minakari, Mohammad, Merat, S., Sohrabi, M., Mansour-Ghanaei, F., Hormati, A., Mokhtare, M., Khoshnia, M., Agah, S.   +19 more
core   +1 more source

Uso del Sofosbuvir y Daclatasvir en el tratamiento de pacientes con hepatitis C / Use of Sofosbuvir and Daclatasvir in the treatment of patients with hepatitis C [PDF]

Introducción: La Infección por el virus de la hepatitis C constituye un problema sanitario a nivel mundial por su elevada incidencia. El tratamiento para esta infección experimentó un cambio en los últimos años con la comercialización de los Antivirales ...
Muñoz Castañeda, Misael Bárbaro, Díaz Elías, Javier Orlando, Fernández Sotolongo, José, Pardías Izaguirre, Yaimara, Ortiz Montero, Yosvani Josué, Arús Soler, Enrique Rogelio   +5 more
core  

Multivariate logistic regression analysis to identify factors associated with liver injuries in patients with genotype 1b HCV receiving daclatasvir plus asunaprevir therapy.

, 2018
Multivariate logistic regression analysis to identify factors associated with liver injuries in patients with genotype 1b HCV receiving daclatasvir plus asunaprevir therapy.
Kayoko Sugawara (5848991), Yukinori Imai (5849006), Nobuaki Nakayama (5849003), Masamitsu Nakao (5848994), Mie Inao (5849000), Satoshi Mochida (156566), Jun-ichi Kouyama (661243), Daisuke Motoya (5848997), Yoshihito Uchida (661242), Kayoko Naiki (661244), Tomoaki Tomiya (479370)   +10 more
core   +1 more source

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience

, 2018
Amro M Hassan,1 Heba A Osman,2 Hasan S Mahmoud,2 Mohammed H Hassan,3 Abdel-Kader A Hashim,4 Hesham H Ameen5 1Tropical Medicine Department, Faculty of Medicine, Al-Azhar University (Assiut Branch), Assiut, Egypt; 2Tropical Medicine and Gastroenterology ...
Osman HA, Ameen HH, Hassan MH, Hashim AA, Hassan AM, Mahmoud HS   +5 more
core  

Increasing competition in pharmaceutical tenders: Patents, treatment guidelines, and centralised procurement of Hepatitis C drugs in Brazil. [PDF]

Glob Public Health
Mercadante E.
europepmc   +1 more source

Unravelling HCV diversity and resistance in Viet Nam: a cross-sectional analysis. [PDF]

Lancet Reg Health West Pac
Le Ngoc C, Chai H, Airey G, Das T, Jennings D, Xu F, Flower B, Marjaneh MM, McCabe L, Le Manh H, Nguyen Van Vinh C, Trong TD, Ngoc TP, Thi Thu HV, Thwaites GE, van Doorn HR, Day J, Kestelyn E, Le Van T, Rahman M, Pett S, Barnes E, Walker AS, Cooke GS, Ansari MA.   +24 more
europepmc   +1 more source